End-of-day quote
Korea S.E.
18:00:00 2024-05-30 EDT
5-day change
1st Jan Change
8,130
KRW
+3.30%
-1.45%
+21.34%
Samil Pharmaceutical Co.,Ltd's Equity Buyback announced on October 5, 2021, has expired with 119,560 shares, representing 0.94% for KRW 996.5 million.
The company expired its plan on October 4, 2022.
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
05-13
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
03-14
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-14
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-14
CI
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 12 billion in funding
23-04-18
CI
Samil Pharmaceutical Co.,Ltd announced that it expects to receive KRW 12 billion in funding
23-04-16
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
22-11-28
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
22-11-28
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
22-11-28
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
22-11-28
CI
Samil Pharmaceutical Co.,Ltd's Equity Buyback announced on November 30, 2021, has expired with 125,939 shares, representing 0.99% for KRW 997.71 million.
22-11-28
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-14
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
22-10-06
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
22-10-06
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
22-10-06
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
22-10-06
CI
Samil Pharmaceutical Co.,Ltd's Equity Buyback announced on October 5, 2021, has expired with 119,560 shares, representing 0.94% for KRW 996.5 million.
22-10-03
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-12
CI
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 4 billion in funding
22-07-27
CI
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 5 billion in funding
22-07-27
CI
Samil Pharmaceutical Co.,Ltd announced that it expects to receive KRW 4 billion in funding
22-07-25
CI
Samil Pharmaceutical Co.,Ltd announced that it expects to receive KRW 5 billion in funding
22-07-25
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-08
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 30, 2021.
22-05-03
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 30, 2021.
22-05-03
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
SAMIL PHARMACEUTICAL CO., LTD is a Korea-based company mainly engaged in the manufacture of medicines. The Companyâs products portfolio consists of gastro-intestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives under the brand names of Plybutine, Gliptide and others; antipyretic, analgesic and anti-inflammatory agents under the brand name Brufen; nutritional supplements such as vitamins, minerals and immunosuppressants, and others including antigout agents, anti-parkinsonism agents and others. In addition, it is engaged in the provision of miscellaneous goods. The Company distributes its products within domestic market and to overseas markets. On November 29, 2013, it transferred its entire shares of a Korea-based company, which is engaged in the sale of medical products.
More about the company
1st Jan change
Capi.
+21.34% 118M +15.91% 41.97B +22.40% 22.34B +18.48% 15.25B +16.12% 14B +45.12% 12.06B -9.58% 6.8B -0.05% 6.79B -8.87% 5.73B +14.18% 5.49B
Generic Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1